Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Henry

Showing results (721-730 of 733) with videos related to

Pageof 74
Sort By:
Nature Microbiology|May 3, 2022
Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in womenColin J Worby, Henry L Schreiber, Timothy J Straub, et al.
Scientific Data|November 22, 2025
Twenty years (2000-2020) of butterfly monitoring data across the contiguous United StatesErica H Henry, Collin B Edwards, Vaughn Shirey, et al.
BMC Urology|August 3, 2014
The MAPP research network: design, patient characterization and operationsJ Richard Landis, David A Williams, M Scott Lucia, et al.
JAMA|November 28, 2018
Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical TrialAleena Banerji, Marc A Riedl, Jonathan A Bernstein, et al.
Environmental Health Perspectives|December 23, 2006
Workgroup report: public health strategies for reducing aflatoxin exposure in developing countriesHeather Strosnider, Eduardo Azziz-Baumgartner, Marianne Banziger, et al.
The Journal of Allergy and Clinical Immunology|October 25, 2020
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trialBruce Zuraw, William R Lumry, Douglas T Johnston, et al.
Science (New York, N.Y.)|March 6, 2025
Rapid butterfly declines across the United States during the 21st centuryCollin B Edwards, Elise F Zipkin, Erica H Henry, et al.
Lancet (London, England)|February 5, 2008
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialDavid J Kuter, James B Bussel, Roger M Lyons, et al.
The Journal of Allergy and Clinical Immunology. Global|July 12, 2026
Sebetralstat for breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis in KONFIDENT-STamar Kinaciyan, Emel Aygören-Pürsün, Inmaculada Martinez-Saguer, et al.
The Lancet. Haematology|March 22, 2026
Oral deucrictibant for on-demand treatment of hereditary angioedema attacks (RAPIDe-1): a randomised, double-blind, placebo-controlled, phase 2 trialMarcus Maurer, Marcin Stobiecki, Anna Valerieva, et al.
Pageof 74

Showing results (721-730 of 733) with videos related to

Sort By:
Pageof 74
Nature Microbiology|May 3, 2022
Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in womenColin J Worby, Henry L Schreiber, Timothy J Straub, et al.
Scientific Data|November 22, 2025
Twenty years (2000-2020) of butterfly monitoring data across the contiguous United StatesErica H Henry, Collin B Edwards, Vaughn Shirey, et al.
BMC Urology|August 3, 2014
The MAPP research network: design, patient characterization and operationsJ Richard Landis, David A Williams, M Scott Lucia, et al.
JAMA|November 28, 2018
Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical TrialAleena Banerji, Marc A Riedl, Jonathan A Bernstein, et al.
Environmental Health Perspectives|December 23, 2006
Workgroup report: public health strategies for reducing aflatoxin exposure in developing countriesHeather Strosnider, Eduardo Azziz-Baumgartner, Marianne Banziger, et al.
The Journal of Allergy and Clinical Immunology|October 25, 2020
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trialBruce Zuraw, William R Lumry, Douglas T Johnston, et al.
Science (New York, N.Y.)|March 6, 2025
Rapid butterfly declines across the United States during the 21st centuryCollin B Edwards, Elise F Zipkin, Erica H Henry, et al.
Lancet (London, England)|February 5, 2008
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialDavid J Kuter, James B Bussel, Roger M Lyons, et al.
The Journal of Allergy and Clinical Immunology. Global|July 12, 2026
Sebetralstat for breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis in KONFIDENT-STamar Kinaciyan, Emel Aygören-Pürsün, Inmaculada Martinez-Saguer, et al.
The Lancet. Haematology|March 22, 2026
Oral deucrictibant for on-demand treatment of hereditary angioedema attacks (RAPIDe-1): a randomised, double-blind, placebo-controlled, phase 2 trialMarcus Maurer, Marcin Stobiecki, Anna Valerieva, et al.
Pageof 74